BioSpace News Archive

Cloud Pharmaceuticals, Inc., announced today they have entered into drug discovery collaboration with GlaxoSmithKline(GSK).

The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will be making an important announcement at the Tobacco Control Forum to mark World No-Tobacco Day.

The U.S Food and Drug Administration (FDA) today approved the first stand-alone prosthetic iris in the United States.

Statement from FDA Commissioner Scott Gottlieb, M.D., on federal preparedness and FDA’s response efforts to the Ebola virus outbreak in the Democratic Republic of Congo

Microbiome Insights, Inc. has announced the opening of its new laboratory on the campus of the University of British Columbia (UBC).

Streamline Health Solutions, Inc. announced it signed a contract with a large West-Coast based academic hospital for Streamline Health eValuator.

Close to 400 guests were on hand at the Caisse de dépôt et placement du Québec for the 5th edition of the Audacious fundraising event, organized by the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and hosted by Stéphan Bureau.

Pfizer Inc. announced that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ® (tofacitinib) 10 mg twice-daily (BID) for at least eight weeks, followed by XELJANZ 5 mg BID or 10 mg BID, for the treatment of adult patients in the U.S. with moderately to severely active ulcerative colitis (UC).

Array BioPharma Inc. announced that its Chief Executive Officer, Ron Squarer, will speak at the Jefferies 2018 Global Healthcare Conference.

Sangamo Therapeutics, Inc. announced that management will present a corporate overview at the 2018 Jefferies Global Healthcare Conference in New York City.